SCHEMBL18327031

SCHEMBL18327031

N#Cc1c(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)c(C#N)c(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)c(C#N)c1-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.52
ATM Q13315 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
PDE9A O76083 1/20 0.43
PDE1C Q14123 1/20 0.43
ALDH1A1 P00352 7/20 0.43
HPGD P15428 5/20 0.43
RXFP1 Q9HBX9 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
GAA P10253 3/20 0.42
HTR3A P46098 1/20 0.39
EGFR P00533 1/20 0.39
SRC P12931 1/20 0.39
HDAC4 P56524 1/20 0.39
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19268495 0.98 KDM4E (0.50) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL17483325 0.97 KDM4E (0.52) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL22216783 0.93 KDM4E (0.53) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL17483445 0.92 KDM4E (0.50) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL24624451 0.91 KDM4E (0.46) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL21378068 0.91 KDM4E (0.46) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL21293787 0.91 KDM4E (0.46) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL21304042 0.91 KDM4E (0.46) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL21293773 0.89 KDM4E (0.44) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL24623461 0.89 KDM4E (0.47) KDM4EATML3MBTL1PDE9APDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4102588-A1 HOST MATERIAL, COMPOSITION, AND ORGANIC ELECTROLUMINESCENT ELEMENT Kyulux, Inc. (JP) 2022-12-14 EP disclosed
US-11335872-B2 Organic light-emitting device KYULUX, INC. (JP) 2022-05-17 US disclosed
US-20210234113-A1 ORGANIC LIGHT-EMITTING DEVICE KYULUX, INC. (JP) 2021-07-29 US disclosed
US-20200035922-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-01-30 US disclosed
US-20190245152-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-08-08 US disclosed
US-20170244049-A1 ORGANIC LIGHT-EMITTING DIODE MATERIALS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-08-24 US disclosed
EP-3112439-A1 LUMINESCENT MATERIAL, ORGANIC LUMINESCENT ELEMENT, AND COMPOUND Kyulux, Inc. (JP) 2017-01-04 EP disclosed
US-20160372682-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND KYULUX, INC. (JP) 2016-12-22 US disclosed
US-20160372682-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND KYULUX, INC. (JP) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170244049-A1 ORGANIC LIGHT-EMITTING DIODE MATERIALS CYBA, DDT, DRD1 KDM4E 2858/4885ATM 1981/4885L3MBTL1 24/4885
US-20160372682-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND CRY1, CRY2, CORO1A KDM4E 3063/4885ATM 1931/4885L3MBTL1 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.